Table 1 Correlation of tissue high and low levels of UBE2N with clinicopathological features of prostate cancer patients
Clinicopathological features | UBE2N | P value | |
|---|---|---|---|
Low (n = 29) | High (n = 61) | ||
Age (years) | 0.418 | ||
< 60 (n = 49) | 14 | 35 | |
≥ 60 (n = 41) | 15 | 26 | |
PSA (ng/ml) | 0.019 | ||
< 4 (n = 34) | 16 | 18 | |
≥ 4 (n = 56) | 13 | 43 | |
T stage | 0.020 | ||
T2 (n = 37) | 17 | 20 | |
T3-4 (n = 53) | 12 | 41 | |
N stage | 0.634 | ||
N0 (n = 65) | 20 | 45 | |
N1 (n = 25) | 9 | 16 | |
M stage | 0.380 | ||
M0 (n = 73) | 22 | 51 | |
M1 (n = 17) | 7 | 10 | |
Gleason score | 0.029 | ||
3–6 (n = 35) | 16 | 19 | |
7–10 (n = 55) | 13 | 42 | |